Skip to content

Drug interactions

Atogepant + Bromocriptine

Severity: Minor

Atogepant and Bromocriptine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Atogepant is a CYP3A4 substrate, and bromocriptine is a weak CYP3A4 inhibitor and substrate. Any increase in atogepant exposure is likely small and of limited clinical significance.

What this interaction means in plain words

Atogepant and Bromocriptine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atogepant belongs to Central Nervous System; Bromocriptine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4-mediated metabolism of atogepant.

What to do

No routine dose change is needed. Monitor for atogepant adverse effects such as nausea, constipation and fatigue.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Bromocriptine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Bromocriptine?

MediHelp rates the interaction as minor. Atogepant and Bromocriptine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Atogepant is a CYP3A4 substrate, and bromocriptine is a weak CYP3A4 inhibitor and substrate. Any increase in atogepant exposure is likely small and of limited clinical significance.

How serious is the interaction between Atogepant and Bromocriptine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor for atogepant adverse effects such as nausea, constipation and fatigue.

What other medicines interact with Bromocriptine?

MediHelp also lists interactions of Bromocriptine with, for example, Amisulpride, Atazanavir, Cobicistat. The full list is on the Bromocriptine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in